10 20 30 40 50 60 70 80 3FLS - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER SIGNALING PROTEIN, TRANSFERASE 19-DEC-08 3FLS
TITLE P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4- TITLE 2 DIFLUORO-PHENOXY)-2-((R)-2-METHANESULFONYL-1-METHYL- TITLE 3 ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MITOGEN-ACTIVATED PROTEIN KINASE P38 ALPHA, MAP COMPND 5 KINASE P38 ALPHA, CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY COMPND 6 DRUG-BINDING PROTEIN, CSAID-BINDING PROTEIN, CSBP, MAX- COMPND 7 INTERACTING PROTEIN 2, MAP KINASE MXI2, SAPK2A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS P38; MAP KINASE; SERINE/THREONINE KINASE, ALTERNATIVE KEYWDS 2 SPLICING, ATP-BINDING, CYTOPLASM, KINASE, NUCLEOTIDE- KEYWDS 3 BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, KEYWDS 4 SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, SIGNALING KEYWDS 5 PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR A.KUGLSTATTER,M.GHATE
REVDAT 1 22-DEC-09 3FLS 0
JRNL AUTH M.SOTH,A.KUGLSTATTER,D.GOLDSTEIN JRNL TITL THE DISCOVERY OF PAMAPIMOD, R1503 AND R1487 AS JRNL TITL 2 ORALLY BIOAVAILABLE AND HIGHLY SELECTIVE INHIBITORS JRNL TITL 3 OF P38 MAP KINASE JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 17229 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 937 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2776 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 31 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.38000 REMARK 3 B22 (A**2) : 4.03000 REMARK 3 B33 (A**2) : -0.64000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 3FLS COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-DEC-08. REMARK 100 THE RCSB ID CODE IS RCSB050747.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18195 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 78.5 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.15700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.31500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM HEPES PH 7.6, 50 MM CACL2, REMARK 280 17% PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.83300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.81400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.37950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.81400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.83300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.37950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -11 REMARK 465 ARG A -10 REMARK 465 GLY A -9 REMARK 465 SER A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 GLY A 33 REMARK 465 ALA A 34 REMARK 465 TYR A 35 REMARK 465 GLY A 36 REMARK 465 ALA A 172 REMARK 465 ARG A 173 REMARK 465 LEU A 353 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 11 128.45 -175.25 REMARK 500 LEU A 13 -69.86 -132.71 REMARK 500 ASN A 14 58.79 -103.91 REMARK 500 LYS A 15 11.23 55.41 REMARK 500 ARG A 57 75.74 42.59 REMARK 500 ASN A 100 5.73 -157.98 REMARK 500 LYS A 118 61.65 35.20 REMARK 500 CYS A 119 -31.69 63.62 REMARK 500 ARG A 149 -14.30 72.22 REMARK 500 ASP A 150 39.99 -146.74 REMARK 500 ASN A 159 -157.27 -90.74 REMARK 500 THR A 175 -167.88 -79.03 REMARK 500 ASP A 227 168.74 175.31 REMARK 500 ASN A 278 118.73 -39.15 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FLS A 361
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3FLN RELATED DB: PDB REMARK 900 RELATED ID: 3FLQ RELATED DB: PDB REMARK 900 RELATED ID: 3FLW RELATED DB: PDB REMARK 900 RELATED ID: 3FLY RELATED DB: PDB REMARK 900 RELATED ID: 3FLZ RELATED DB: PDB REMARK 900 RELATED ID: 3FMH RELATED DB: PDB REMARK 900 RELATED ID: 3FMJ RELATED DB: PDB REMARK 900 RELATED ID: 3FMK RELATED DB: PDB
DBREF 3FLS A 1 360 UNP Q16539 MK14_HUMAN 1 360
SEQADV 3FLS MET A -11 UNP Q16539 EXPRESSION TAG SEQADV 3FLS ARG A -10 UNP Q16539 EXPRESSION TAG SEQADV 3FLS GLY A -9 UNP Q16539 EXPRESSION TAG SEQADV 3FLS SER A -8 UNP Q16539 EXPRESSION TAG SEQADV 3FLS HIS A -7 UNP Q16539 EXPRESSION TAG SEQADV 3FLS HIS A -6 UNP Q16539 EXPRESSION TAG SEQADV 3FLS HIS A -5 UNP Q16539 EXPRESSION TAG SEQADV 3FLS HIS A -4 UNP Q16539 EXPRESSION TAG SEQADV 3FLS HIS A -3 UNP Q16539 EXPRESSION TAG SEQADV 3FLS HIS A -2 UNP Q16539 EXPRESSION TAG SEQADV 3FLS GLY A -1 UNP Q16539 EXPRESSION TAG SEQADV 3FLS SER A 0 UNP Q16539 EXPRESSION TAG
SEQRES 1 A 372 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER MET SEQRES 2 A 372 SER GLN GLU ARG PRO THR PHE TYR ARG GLN GLU LEU ASN SEQRES 3 A 372 LYS THR ILE TRP GLU VAL PRO GLU ARG TYR GLN ASN LEU SEQRES 4 A 372 SER PRO VAL GLY SER GLY ALA TYR GLY SER VAL CYS ALA SEQRES 5 A 372 ALA PHE ASP THR LYS THR GLY LEU ARG VAL ALA VAL LYS SEQRES 6 A 372 LYS LEU SER ARG PRO PHE GLN SER ILE ILE HIS ALA LYS SEQRES 7 A 372 ARG THR TYR ARG GLU LEU ARG LEU LEU LYS HIS MET LYS SEQRES 8 A 372 HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL PHE THR PRO SEQRES 9 A 372 ALA ARG SER LEU GLU GLU PHE ASN ASP VAL TYR LEU VAL SEQRES 10 A 372 THR HIS LEU MET GLY ALA ASP LEU ASN ASN ILE VAL LYS SEQRES 11 A 372 CYS GLN LYS LEU THR ASP ASP HIS VAL GLN PHE LEU ILE SEQRES 12 A 372 TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER ALA SEQRES 13 A 372 ASP ILE ILE HIS ARG ASP LEU LYS PRO SER ASN LEU ALA SEQRES 14 A 372 VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU ASP PHE GLY SEQRES 15 A 372 LEU ALA ARG HIS THR ASP ASP GLU MET THR GLY TYR VAL SEQRES 16 A 372 ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SEQRES 17 A 372 TRP MET HIS TYR ASN GLN THR VAL ASP ILE TRP SER VAL SEQRES 18 A 372 GLY CYS ILE MET ALA GLU LEU LEU THR GLY ARG THR LEU SEQRES 19 A 372 PHE PRO GLY THR ASP HIS ILE ASP GLN LEU LYS LEU ILE SEQRES 20 A 372 LEU ARG LEU VAL GLY THR PRO GLY ALA GLU LEU LEU LYS SEQRES 21 A 372 LYS ILE SER SER GLU SER ALA ARG ASN TYR ILE GLN SER SEQRES 22 A 372 LEU THR GLN MET PRO LYS MET ASN PHE ALA ASN VAL PHE SEQRES 23 A 372 ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU LEU GLU LYS SEQRES 24 A 372 MET LEU VAL LEU ASP SER ASP LYS ARG ILE THR ALA ALA SEQRES 25 A 372 GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN TYR HIS ASP SEQRES 26 A 372 PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR ASP GLN SER SEQRES 27 A 372 PHE GLU SER ARG ASP LEU LEU ILE ASP GLU TRP LYS SER SEQRES 28 A 372 LEU THR TYR ASP GLU VAL ILE SER PHE VAL PRO PRO PRO SEQRES 29 A 372 LEU ASP GLN GLU GLU MET GLU SER
HET FLS A 361 29
HETNAM FLS 6-(2,4-DIFLUOROPHENOXY)-8-METHYL-2-{[(1R)-1-METHYL-2- HETNAM 2 FLS (METHYLSULFONYL)ETHYL]AMINO}PYRIDO[2,3-D]PYRIMIDIN- HETNAM 3 FLS 7(8H)-ONE
FORMUL 2 FLS C18 H18 F2 N4 O4 S FORMUL 3 HOH *31(H2 O)
HELIX 1 1 SER A 61 MET A 78 1 18 HELIX 2 2 LEU A 113 LYS A 118 1 6 HELIX 3 3 THR A 123 ALA A 144 1 22 HELIX 4 4 LYS A 152 SER A 154 5 3 HELIX 5 5 ALA A 190 LEU A 195 1 6 HELIX 6 6 THR A 203 GLY A 219 1 17 HELIX 7 7 ASP A 227 GLY A 240 1 14 HELIX 8 8 GLY A 243 ILE A 250 1 8 HELIX 9 9 SER A 252 GLN A 260 1 9 HELIX 10 10 ASN A 269 PHE A 274 1 6 HELIX 11 11 ASN A 278 LEU A 289 1 12 HELIX 12 12 THR A 298 ALA A 304 1 7 HELIX 13 13 HIS A 305 ALA A 309 5 5 HELIX 14 14 ASP A 313 GLU A 317 5 5 HELIX 15 15 GLN A 325 ARG A 330 5 6 HELIX 16 16 LEU A 333 PHE A 348 1 16
SHEET 1 A 2 PHE A 8 TYR A 9 0 SHEET 2 A 2 VAL A 20 PRO A 21 -1 O VAL A 20 N TYR A 9 SHEET 1 B 5 TYR A 24 GLY A 31 0 SHEET 2 B 5 VAL A 38 ASP A 43 -1 O ALA A 40 N SER A 28 SHEET 3 B 5 ARG A 49 LYS A 54 -1 O VAL A 50 N ALA A 41 SHEET 4 B 5 TYR A 103 HIS A 107 -1 O LEU A 104 N LYS A 53 SHEET 5 B 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 C 3 ALA A 111 ASP A 112 0 SHEET 2 C 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 C 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157
SITE 1 AC1 14 VAL A 30 SER A 32 VAL A 38 ALA A 51 SITE 2 AC1 14 LYS A 53 ILE A 84 LEU A 86 LEU A 104 SITE 3 AC1 14 VAL A 105 THR A 106 HIS A 107 MET A 109 SITE 4 AC1 14 GLY A 110 ASP A 112
CRYST1 45.666 86.759 127.628 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021898 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011526 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007835 0.00000